On Sep. 1, 2016, NCATS announced a new funding opportunity via its Discovering New Therapeutic Uses for Existing Molecules (New Therapeutic Uses) program. The New Therapeutic Uses Bench-to-Clinic Repurposing initiative aims to support investigators to repurpose ― or identify new uses for — existing experimental drugs or biologics as well as Food and Drug Administration-approved therapies already on the market. NCATS seeks applications to support pre-clinical (bench) studies to test the effectiveness of using an independent crowd sourcing effort, computational algorithm or big dataset from patient records to predict new uses of a drug or biologic.
Letter of Intent Deadline: Oct. 14, 2016
Applications Due: Nov. 14, 2016